• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮细胞结构的破坏是由 PTEN 的缺失或致癌突变体 p110α/PIK3CA 引起的,但不是由 HER2 或突变 AKT1 引起的。

Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1.

机构信息

Division of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, UK.

出版信息

Oncogene. 2013 Sep 12;32(37):4417-26. doi: 10.1038/onc.2012.459. Epub 2012 Oct 22.

DOI:10.1038/onc.2012.459
PMID:23085752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3648380/
Abstract

Genetic changes in HER2, PTEN, PIK3CA and AKT1 are all common in breast cancer and lead to the elevated phosphorylation of downstream targets of the PI3K/AKT signalling pathway. Changes in HER2, PTEN, PIK3CA and AKT have all been reported to lead to both enhanced proliferation and failures in hollow lumen formation in three dimensional epithelial culture models, but it is not clear whether these failures in lumen formation are caused by any failure in the spatial coordination of lumen formation (hollowing) or purely a failure in the apoptosis and clearance of luminal cells (cavitation). Here, we use normal murine mammary gland (NMuMG) epithelial cells, which form a hollow lumen without significant apoptosis, to compare the transformation by these four genetic changes. We find that either mutant PIK3CA expression or PTEN loss, but not mutant AKT1 E17K, cause disrupted epithelial architecture, whereas HER2 overexpression drives strong proliferation without affecting lumen formation in these cells. We also show that PTEN requires both lipid and protein phosphatase activity, its extreme C-terminal PDZ binding sequence and probably Myosin 5A to control lumen formation through a mechanism that does not correlate with its ability to control AKT, but which is selectively lost through mutation in some tumours. These findings correlate AKT-independent signalling activated by mutant PIK3CA or PTEN loss, but not strongly by HER2, with disrupted epithelial architecture and tumour formation.

摘要

HER2、PTEN、PIK3CA 和 AKT1 的遗传变化在乳腺癌中都很常见,导致 PI3K/AKT 信号通路下游靶标的磷酸化水平升高。HER2、PTEN、PIK3CA 和 AKT 的变化都被报道导致三维上皮培养模型中细胞增殖增强和中空腔形成失败,但尚不清楚这些腔形成失败是由于腔形成(凹陷)的空间协调失败还是单纯由于管腔细胞的凋亡和清除(空化)失败。在这里,我们使用正常的小鼠乳腺上皮 (NMuMG) 细胞,这些细胞在没有明显凋亡的情况下形成中空腔,来比较这四种遗传变化的转化。我们发现,只有突变 PIK3CA 的表达或 PTEN 的缺失,但不是突变 AKT1 E17K,会导致上皮结构紊乱,而 HER2 的过表达则会驱动强烈的增殖,而不会影响这些细胞中空腔的形成。我们还表明,PTEN 需要脂质和蛋白磷酸酶活性、其极端 C 末端 PDZ 结合序列和可能的肌球蛋白 5A 来控制腔形成,通过一种与 AKT 控制能力无关的机制,但在某些肿瘤中通过突变选择性丧失。这些发现将突变 PIK3CA 或 PTEN 缺失激活的 AKT 非依赖性信号与上皮结构紊乱和肿瘤形成相关联,但与 HER2 相关性不强。

相似文献

1
Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1.上皮细胞结构的破坏是由 PTEN 的缺失或致癌突变体 p110α/PIK3CA 引起的,但不是由 HER2 或突变 AKT1 引起的。
Oncogene. 2013 Sep 12;32(37):4417-26. doi: 10.1038/onc.2012.459. Epub 2012 Oct 22.
2
Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.致癌性AKT1(E17K)突变诱导乳腺增生,但可阻止HER2驱动的肿瘤发生。
Oncotarget. 2016 Apr 5;7(14):17301-13. doi: 10.18632/oncotarget.8191.
3
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.肺癌中PTEN/PI3K/AKT途径内发生的多种致癌改变所诱导的特定基因表达特征。
PLoS One. 2017 Jun 29;12(6):e0178865. doi: 10.1371/journal.pone.0178865. eCollection 2017.
4
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.基底样乳腺癌细胞中频繁的PTEN基因改变和激活的磷脂酰肌醇3-激酶途径。
Breast Cancer Res. 2008;10(6):R101. doi: 10.1186/bcr2204. Epub 2008 Dec 3.
5
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition.HER2 抑制后 PI3K/PTEN/AKT 信号网络中可逆的敏感性-抗性转换的特征。
Cell Signal. 2012 Feb;24(2):493-504. doi: 10.1016/j.cellsig.2011.09.030. Epub 2011 Oct 4.
6
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.PI3K-p110α介导HER2阳性、PTEN缺失的乳腺癌对HER2靶向治疗的耐药性。
Oncogene. 2016 Jul 7;35(27):3607-12. doi: 10.1038/onc.2015.406. Epub 2015 Oct 26.
7
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.PIK3CA 突变和 EGFR 过表达可预测人乳腺上皮细胞对锂的敏感性。
Cancer Biol Ther. 2011 Feb 1;11(3):358-67. doi: 10.4161/cbt.11.3.14227.
8
PI3K pathway dependencies in endometrioid endometrial cancer cell lines.PI3K 通路依赖性在子宫内膜样癌细胞系中的研究。
Clin Cancer Res. 2013 Jul 1;19(13):3533-44. doi: 10.1158/1078-0432.CCR-12-3815. Epub 2013 May 14.
9
PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.PTEN、PIK3CA、p-AKT 和 p-p70S6K 状态:与曲妥珠单抗治疗 HER2 阳性转移性乳腺癌患者的反应和生存的相关性。
Am J Pathol. 2010 Oct;177(4):1647-56. doi: 10.2353/ajpath.2010.090885. Epub 2010 Sep 2.
10
[Characterization of PIK3CA/AKT1/PTEN gene mutations in hormone receptor- positive/HER2-negative breast cancer].激素受体阳性/人表皮生长因子受体2阴性乳腺癌中PIK3CA/AKT1/PTEN基因突变的特征分析
Zhonghua Bing Li Xue Za Zhi. 2025 May 8;54(5):500-505. doi: 10.3760/cma.j.cn112151-20240819-00552.

引用本文的文献

1
PTEN Protein Phosphatase Activity Is Not Required for Tumour Suppression in the Mouse Prostate.PTEN 蛋白磷酸酶活性对于小鼠前列腺中的肿瘤抑制并非必需。
Biomolecules. 2022 Oct 19;12(10):1511. doi: 10.3390/biom12101511.
2
Genetic analysis of DAF-18/PTEN missense mutants for the ability to maintain quiescence of the somatic gonad and germ line in Caenorhabditis elegans dauer larvae.DAF-18/PTEN 错义突变体维持 Caenorhabditis elegans dauer 幼虫体生殖腺和生殖系静止能力的遗传分析。
G3 (Bethesda). 2022 May 30;12(6). doi: 10.1093/g3journal/jkac093.
3
PTEN suppresses epithelial-mesenchymal transition and cancer stem cell activity by downregulating Abi1.PTEN 通过下调 Abi1 抑制上皮-间充质转化和癌症干细胞活性。
Sci Rep. 2020 Jul 29;10(1):12685. doi: 10.1038/s41598-020-69698-1.
4
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments.乳腺癌:一种需要亚型特异性治疗的分子异质性疾病。
Med Sci (Basel). 2020 Mar 23;8(1):18. doi: 10.3390/medsci8010018.
5
PBRM1 Regulates Stress Response in Epithelial Cells.PBRM1调节上皮细胞中的应激反应。
iScience. 2019 May 31;15:196-210. doi: 10.1016/j.isci.2019.04.027. Epub 2019 Apr 26.
6
Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.致癌性 PIK3CA 突变增加了乳腺癌细胞对 mRNA 帽甲基转移酶 RNMT 的依赖性。
Open Biol. 2019 Apr 26;9(4):190052. doi: 10.1098/rsob.190052.
7
Tight junction proteins in gastrointestinal and liver disease.胃肠道和肝脏疾病中的紧密连接蛋白。
Gut. 2019 Mar;68(3):547-561. doi: 10.1136/gutjnl-2018-316906. Epub 2018 Oct 8.
8
The Phosphatase PTPL1 Is Required for PTEN-Mediated Regulation of Apical Membrane Size.磷酸酶 PTPL1 对于 PTEN 介导的顶端膜大小的调节是必需的。
Mol Cell Biol. 2018 May 29;38(12). doi: 10.1128/MCB.00102-18. Print 2018 Jun 15.
9
Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.致癌性 PI3K 通过胱氨酸-谷氨酸反向转运蛋白 xCT 促进乳腺癌细胞对蛋氨酸的依赖性。
Sci Signal. 2017 Dec 19;10(510):eaao6604. doi: 10.1126/scisignal.aao6604.
10
Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells.锌转运蛋白 2 与液泡型 ATP 酶相互作用,是乳腺上皮细胞极化、囊泡酸化和分泌所必需的。
J Biol Chem. 2017 Dec 29;292(52):21598-21613. doi: 10.1074/jbc.M117.794461. Epub 2017 Nov 7.

本文引用的文献

1
PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.PTEN 蛋白磷酸酶活性与基因表达和侵袭的控制相关,表现出肿瘤抑制表型,但与 AKT 活性无关。
Sci Signal. 2012 Feb 28;5(213):ra18. doi: 10.1126/scisignal.2002138.
2
PI3K signalling: the path to discovery and understanding.PI3K 信号通路:探索与理解之路。
Nat Rev Mol Cell Biol. 2012 Feb 23;13(3):195-203. doi: 10.1038/nrm3290.
3
Outgrowth of single oncogene-expressing cells from suppressive epithelial environments.单一癌基因表达细胞从抑制性上皮环境中的生长。
Nature. 2012 Feb 8;482(7385):410-3. doi: 10.1038/nature10826.
4
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.致癌性 PIK3CA 驱动的乳腺肿瘤经常通过 PI3K 通路依赖性和非依赖性机制复发。
Nat Med. 2011 Aug 7;17(9):1116-20. doi: 10.1038/nm.2402.
5
Epithelial organization, cell polarity and tumorigenesis.上皮组织、细胞极性与肿瘤发生。
Trends Cell Biol. 2011 Dec;21(12):727-35. doi: 10.1016/j.tcb.2011.06.005. Epub 2011 Jul 21.
6
Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors.PIK3CA 突变型 H1047R 在乳腺中的腔面表达可诱导异质性肿瘤。
Cancer Res. 2011 Jul 1;71(13):4344-51. doi: 10.1158/0008-5472.CAN-10-3827. Epub 2011 Apr 11.
7
Molecular regulation of lumen morphogenesis.腔管形态发生的分子调控。
Curr Biol. 2011 Feb 8;21(3):R126-36. doi: 10.1016/j.cub.2010.12.003.
8
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.在人乳腺上皮细胞中敲入 AKT1 E17K 突变不能重现致癌性 PIK3CA 突变。
Oncogene. 2010 Apr 22;29(16):2337-45. doi: 10.1038/onc.2009.516. Epub 2010 Jan 25.
9
Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.PTEN 通过协调脂质和蛋白磷酸酶活性抑制细胞增殖和侵袭。
Oncogene. 2010 Feb 4;29(5):687-97. doi: 10.1038/onc.2009.384. Epub 2009 Nov 16.
10
Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.IA类磷酸肌醇3激酶的螺旋结构域和激酶结构域突变对乳腺癌细胞迁移和转移的差异增强作用
Cancer Res. 2009 Dec 1;69(23):8868-76. doi: 10.1158/0008-5472.CAN-09-1968. Epub 2009 Nov 10.